Chiron Corporation, headquartered in Emeryville, California, is a globapharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people’s lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: biopharmaceuticals, vaccines and blood testing.
People
Pieter Strijkert (Board Member)
Meghan Leader (CIO)
William Green (Senior Counsel)
Paul Herrling (Board Member)
Lewis Coleman (Board Member)
Competitors
GlaxoSmithKline:
We have a challenging and inspiring mission: to improve the quality of human life by enabling… See Company Profile »
News
Halo Reach needs reverse tag
May 4, 2010 2:06 pm
(this is a copy paste of a forum post i made on the Halo: Reach beta feedback forum at http://www.bungie.net/Forums/posts.aspx?postID=43703817… Continue reading ⟩
S*BIO takes $26M for cancer therapeutics
October 20, 2008 4:48 pm
Pharmaceutical company S*BIO announced today that it raised $26 million in second-round funding to help push two new cancer treatment… Continue reading ⟩
Tethys predicts your potential diabetic future
January 22, 2008 3:30 pm
Suppose a simple blood test were to tell you that you’ve got a better than 50 percent chance of developing… Continue reading ⟩